| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 5 | NIH | 3/21/2024 | $0 |
| | 2024 | 2023 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 5 | NIH | 3/21/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $311,370 ) |
| | 2023 | 2023 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | R01MH123508 | Elucidating the neural mechanisms behind transcranial direct current stimulation | 000 | 4 | NIH | 4/24/2023 | $209,189 |
| | 2023 | 2023 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 001 | 5 | NIH | 6/1/2023 | $91,681 |
| | 2023 | 2023 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 001 | 5 | NIH | 6/1/2023 | $10,500 |
| | 2023 | 2022 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 4 | NIH | 1/11/2023 | $0 |
| | 2023 | 2022 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 4 | NIH | 1/11/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $308,624 ) |
| | 2022 | 2022 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | R01MH123508 | Elucidating the neural mechanisms behind transcranial direct current stimulation | 000 | 3 | NIH | 4/20/2022 | $209,188 |
| | 2022 | 2022 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 4 | NIH | 3/24/2022 | $88,936 |
| | 2022 | 2022 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 4 | NIH | 3/24/2022 | $10,500 |
|
| Issue Date FY: 2021 ( Subtotal = $311,054 ) |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 002 | 3 | NIH | 8/11/2021 | -$91,366 |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 3 | NIH | 4/6/2021 | $10,500 |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 3 | NIH | 4/6/2021 | $91,366 |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 001 | 3 | NIH | 8/10/2021 | $91,366 |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 001 | 3 | NIH | 8/10/2021 | -$91,366 |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | R01MH123508 | Elucidating the neural mechanisms behind transcranial direct current stimulation | 000 | 2 | NIH | 4/12/2021 | $209,188 |
| | 2021 | 2021 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 002 | 3 | NIH | 8/11/2021 | $91,366 |
|
| Issue Date FY: 2020 ( Subtotal = $321,470 ) |
| | 2020 | 2020 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | R01MH123508 | Elucidating the neural mechanisms behind transcranial direct current stimulation | 000 | 1 | NIH | 6/26/2020 | $217,174 |
| | 2020 | 2020 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 2 | NIH | 4/2/2020 | $10,500 |
| | 2020 | 2020 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 2 | NIH | 4/2/2020 | $93,796 |
|
| Issue Date FY: 2019 ( Subtotal = $101,020 ) |
| | 2019 | 2019 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 1 | NIH | 6/20/2019 | $94,501 |
| | 2019 | 2019 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | U01MH119759 | Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders | 000 | 1 | NIH | 6/20/2019 | $10,500 |
| | 2019 | 2016 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | F32AR069459 | Quantitative measurement of soft tissue knee balance after TKA using ultrasound elastography | 000 | 1 | NIH | 6/20/2019 | -$3,980 |
| | 2019 | 2016 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | U01MH101722 | "4/5 International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome" | 000 | 4 | NIH | 1/7/2019 | -$1 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2016 | KATHOLIEKE UNIVERSITEIT TE LEUVEN | OUDE MARKT 13 | LEUVEN | LEUVEN | 3000 | | BEL | F32AR069459 | Quantitative measurement of soft tissue knee balance after TKA using ultrasound elastography | 001 | 1 | NIH | 7/7/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $276,309 ) |
| | 2016 | 2016 | KATHOLIEKE UNIVERSITEIT LEUVEN | OUDE MARKT 13 | LEUVEN | | | | BEL | U01MH101722 | "4/5 International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome" | 000 | 4 | NIH | 7/18/2016 | $276,309 |
|
| Issue Date FY: 2015 ( Subtotal = $330,632 ) |
| | 2015 | 2015 | KATHOLIEKE UNIVERSITEIT LEUVEN | OUDE MARKT 13 | LEUVEN | | | | BEL | U01MH101722 | "4/5 International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome" | 000 | 3 | NIH | 8/24/2015 | $330,632 |
|
| Issue Date FY: 2014 ( Subtotal = $331,497 ) |
| | 2014 | 2014 | KATHOLIEKE UNIVERSITEIT LEUVEN | OUDE MARKT 13 | LEUVEN | | | | BEL | U01MH101722 | "4/5 International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome" | 000 | 2 | NIH | 8/12/2014 | $331,497 |
|
| Issue Date FY: 2013 ( Subtotal = $333,329 ) |
| | 2013 | 2013 | K. U. LEUVEN UNIVERSITEITSHAL | NihFinal.dat | LEUVEN | | | | BEL | U01MH101722 | "4/5 International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome" | 000 | 1 | NIH | 9/26/2013 | $333,329 |
|
| Issue Date FY: 2004 ( Subtotal = $1,610,556 ) |
| | 2004 | 2004 | KATHOLIEKE UNIVERSITEIT LEUVEN | NOOMSESTRAAT 22 | LEUVEN | | 3000 | | BEL | UC1AI062540 | NOVEL INHIBITORS OF THE REPLICATION OF POXVIRUSES | 000 | 1 | NIH | 9/30/2004 | $1,610,556 |
|
|
